← Back to Search

EMG-Controlled Game Therapy for Stroke (GAM Trial)

N/A
Waitlist Available
Led By Na Jin Seo, PhD MS BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18+ years old
Moderate upper limb impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week from intervention completion
Awards & highlights

GAM Trial Summary

This trial will test if specially tailored physical therapy can improve upper limb function in stroke survivors over 2.5 months.

Who is the study for?
This trial is for stroke survivors over 18 years old with moderate upper limb impairment, who can see a computer screen and have the cognitive ability to follow study procedures. It's not suitable for those with severe language or cognitive barriers, total sensory loss in the limbs, ongoing arm rehab, extreme muscle stiffness preventing movement, recent spasticity treatment changes, or other conditions affecting arm use.Check my eligibility
What is being tested?
The study tests whether practicing muscle activation patterns and task practice can improve arm function after a stroke. Participants will visit the lab three times weekly for six weeks to engage in these activities and will also attend three additional visits for assessments of their arm function over about 2.5 months.See study design
What are the potential side effects?
Since this intervention involves physical therapy exercises rather than medication, typical side effects associated with drugs are not expected. However, participants may experience fatigue or discomfort from the exercises.

GAM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have moderate difficulty using my arms.
Select...
I can see the full computer screen clearly.

GAM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week from intervention completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week from intervention completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Wolf Motor Function Test

GAM Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EMG + task trainingExperimental Treatment2 Interventions
Train with EMG-controlled games and functional task practice
Group II: task trainingActive Control1 Intervention
Train with functional task practice for a total of 18 sessions

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,612 Previous Clinical Trials
3,305,681 Total Patients Enrolled
83 Trials studying Stroke
6,656 Patients Enrolled for Stroke
Na Jin Seo, PhD MS BSPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC
2 Previous Clinical Trials
66 Total Patients Enrolled
2 Trials studying Stroke
66 Patients Enrolled for Stroke

Media Library

practice muscle activation patterns Clinical Trial Eligibility Overview. Trial Name: NCT05628324 — N/A
Stroke Research Study Groups: EMG + task training, task training
Stroke Clinical Trial 2023: practice muscle activation patterns Highlights & Side Effects. Trial Name: NCT05628324 — N/A
practice muscle activation patterns 2023 Treatment Timeline for Medical Study. Trial Name: NCT05628324 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still available vacancies for participants in this experiment?

"According to the data shared on clinicaltrials.gov, this medical investigation is not accepting new participants at present. The trial was first posted in July of 2023 and last edited November 16th 2022; however, there are 1,043 other trials that currently require enrolment."

Answered by AI
~41 spots leftby Mar 2027